ed silverman (@edsilverman) profile picture

ed silverman

@edsilverman

Pharmalot columnist and senior writer at @STATnews.. former WSJer.. proud dad; likes music, dogs and taking naps

statnews.com/pharmalot/
Joined November 2008
  • Tweets282
  • Following140
  • Followers5.5K
1Media
Photo by ed silverman (@edsilverman)
FDA scolds Merz over ‘misleading’ Instagram posts featuring interior designer Nate Berkus.. statnews.com/pharmalot/2024/…… #pharma #FDA #botox #wrinkles #Instagram

FDA scolds Merz over 'misleading' Instagram posts featuring interior designer Nate Berkus

For a fifth time this year, the FDA has scolded a pharma company for misleading marketing, this time over a Merz Pharmaceutical rival to Botox.

statnews.com
1
3
774
Student group that ranked med schools over industry conflicts votes to accept pharma funding.. statnews.com/pharmalot/2024/… #pharma #medicine #MedicalEducation #medschool #conflicts
Student group that ranked med schools over industry conflicts votes to accept pharma funding

Student group that ranked med schools over industry conflicts votes to accept pharma funding

An organization devoted to educating future doctors about conflicts of interest will now accept industry funding due to financial stress, prompting outrage from former members.

statnews.com
2
8
828
““The whole purpose of biosimilars was to introduce competition into the marketplace," said study author Ben Rome. "...The fact that it’s so hard to find savings consistently is disappointing." statnews.com/pharmalot/2024/… #pharma #biotech #biologics #biosimilars #medicines
Biosimilars haven't always yielded lower out-of-pocket costs for patients, study finds

Biosimilars haven't always yielded lower out-of-pocket costs for patients, study finds

The authors of a new study argue the heralded arrival of biosimilars failed to fully deliver on their promise.

statnews.com
1
4
683
“Colombia is planting a flag for global health equity,” said Peter Maybarduk of Public Citizen. “This will inspire new challenges to patent barriers and improve treatment access, towards an AIDS-free generation." statnews.com/pharmalot/2024/… #patents #medicines #Colombia #HIV $GSK
Colombia issues a compulsory license for an HIV medicine and 'plants a flag for global health...

Colombia issues a compulsory license for an HIV medicine and 'plants a flag for global health...

“Colombia is planting a flag for global health equity,” said Peter Maybarduk, who heads the access to medicines campaign at Public Citizen.

statnews.com
3
12
1,001
“The messages are filled with misinformation that is hard to set straight because it is such a complicated topic and patients are made to feel like their lives are at stake" statnews.com/pharmalot/2024/… #pharma #RareDiseases #medicines #drugs #Colorado #Enbrel $AMGN $VRTX
Pharma companies and their allies seek to exempt orphan drugs from state pricing limits

Pharma companies and their allies seek to exempt orphan drugs from state pricing limits

As more states create dedicated boards to cap the costs of medicines, some drugmakers and their allies are pushing back with a controversial tactic.

statnews.com
2
451
After nearly 30 years covering pharma, you might think I know it all. Here's your chance to find out... you can Ask Me Anything on Thursday, Feb. 15 at 1 pm ET.. click on this STAT+ Connect link to sign up... connect.statnews.com/landing
Image from ed silverman (@edsilverman)
7
9
1,937
CMS will use outcomes-based agreements in bid to help Medicaid pay for sickle cell gene therapies.. statnews.com/pharmalot/2024/… #pharma #Medicaid #CMS #medicines #sicklecell $VRTX $CRSP $BLUE
CMS will use outcomes-based agreements in bid to help Medicaid pay for sickle cell gene therapies

CMS will use outcomes-based agreements in bid to help Medicaid pay for sickle cell gene therapies

The U.S. government announced a long-awaited “access model” designed to blunt the cost that state Medicaid programs would pay for new sickle cell therapies.

statnews.com
2
1
5
1,366
Pricey sickle cell treatments raise daunting new challenges for Medicaid programs.. statnews.com/pharmalot/2024/… #pharma #sicklecell #Medicaid $VRTX $CRSP $BLUE
Pricey sickle cell treatments raise daunting new challenges for Medicaid programs

Pricey sickle cell treatments raise daunting new challenges for Medicaid programs

Anywhere from 30,000 to 40,000 sickle patients on Medicaid might be eligible for one of the new sickle cell gene therapies. But their cost could prove to be an issue.

statnews.com
1
593
When it comes to policing pharma, the FTC says it’s on ‘an incredible winning streak’.. statnews.com/pharmalot/2024/… #pharma #FTC #antitrust #monopoly #Biden #rebates #patents #mergers $CVS $AMGN $UNH $CI $GSK $AZN $SNY
When it comes to policing pharma, the FTC says it's on 'an incredible winning streak'

When it comes to policing pharma, the FTC says it's on 'an incredible winning streak'

The FTC has attempted to crack down on the pharma industry over concerns that drug companies too often use various means to thwart competition. Here's an update on its progress.

statnews.com
1
721
Patent thickets and terminal disclaimers: How pharma blocks biosimilars from the marketplace.. statnews.com/pharmalot/2023/… #pharma #biotech #biosimilar #patents
Patent thickets and terminal disclaimers: How pharma blocks biosimilars from the marketplace

Patent thickets and terminal disclaimers: How pharma blocks biosimilars from the marketplace

A new study examines tools that pharma companies use to keep drug prices high and competition low: patent thickets and terminal disclaimers.

statnews.com
1
3
328
‘We’ve exhausted all avenues’: A small biotech may give up on its ultra-rare disease drug over frustration with FDA.. statnews.com/pharmalot/2023/… #pharma #biotech #FDA #raredisease #orphandrug
'We’ve exhausted all avenues': A small biotech may give up on its ultra-rare disease drug over...

'We’ve exhausted all avenues': A small biotech may give up on its ultra-rare disease drug over...

"We’ve exhausted all avenues": A small biotech may give up on its ultra-rare disease drug over frustration with the FDA.

statnews.com
1
1
4
441
Was Amgen less than forthcoming about FDA’s concerns on its cancer drug?.. my latest column.. feedback, suggestions, criticism are welcome.. statnews.com/2023/10/04/amge…… #pharma #biotech #cancer #FDA #transparency #clinicaltrials $AMGN
Was Amgen less than forthcoming about FDA's concerns on its cancer drug?

Was Amgen less than forthcoming about FDA's concerns on its cancer drug?

Some analysts are questioning whether Amgen was fully forthcoming about a pricey lung cancer drug that is supposed to generate key revenue growth.

statnews.com
1
1
6
1,056
Colombia set to issue a compulsory license for an HIV medicine sold by GSK’s ViiV.. statnews.com/pharmalot/2023/… #pharma #patent #HIV #AIDS #Colombia $GSK $PFE
Colombia set to issue a compulsory license for an HIV medicine sold by GSK's ViiV

Colombia set to issue a compulsory license for an HIV medicine sold by GSK's ViiV

Colombian authorities are set to issue a compulsory license for a needed HIV treatment, a step that underscores friction between the pharmaceutical industry and cash-strapped governments.

statnews.com
1
5
679
J&J agrees not to enforce patents on a key tuberculosis drug in dozens of poor countries.. statnews.com/pharmalot/2023/… #pharma #patents #TB #tuberculosis #medicine $JNJ
J&J agrees not to enforce patents on a key tuberculosis drug in dozens of poor countries

J&J agrees not to enforce patents on a key tuberculosis drug in dozens of poor countries

Johnson & Johnson announced it would not enforce any of its patents for a key tuberculosis drug in 134 low- and middle-income countries.

statnews.com
4
6
736
Drug wholesaler owner indicted for alleged role in diverting Gilead and J&J HIV medicines.. read the indictment here.. statnews.com/pharmalot/2023/… #pharma #HIV #counterfeit $GILD $JNJ
Drug wholesaler owner indicted for alleged role in diverting Gilead and J&J HIV medicines

Drug wholesaler owner indicted for alleged role in diverting Gilead and J&J HIV medicines

The owner of a drug wholesaler has been indicted for buying steeply discounted HIV medicines from patients and repackaging them for distribution at higher prices.

statnews.com
4
3
1,151
SEC charges former Pfizer statistician with insider trading over Paxlovid clinical trial results.. statnews.com/pharmalot/2023/… #pharma #SEC #insidertrading #Paxlovid $PFE

SEC charges former Pfizer statistician with insider trading over Paxlovid clinical trial results

A former Pfizer statistician was charged by U.S. authorities with insider trading for acting on advance information about trial results for the Paxlovid Covid-19 treatment.

statnews.com
1
4
745
Gilead defeats federal government in closely watched battle over patents for HIV prevention pills.. statnews.com/pharmalot/2023/… #pharma #patents #HIV #AIDS #CDC #HHS $GILD
Gilead defeats federal government in closely watched battle over patents for HIV prevention pills

Gilead defeats federal government in closely watched battle over patents for HIV prevention pills

A U.S. court jury handed a major win to Gilead Sciences on Tuesday in a closely watched battle with the federal government over the rights to groundbreaking HIV prevention pills.

statnews.com
1
1
542
‘True disruption’: Mark Cuban’s company will sell brand-name diabetes medicines from J&J.. statnews.com/pharmalot/2023/… #pharma #diabetes $JNJ
'True disruption': Mark Cuban's company will sell brand-name diabetes medicines from J&J

'True disruption': Mark Cuban's company will sell brand-name diabetes medicines from J&J

"What Mark Cuban and his team have done is true disruption, and is terrific for patients,” said Walid Gellad.

statnews.com
2
724
European Union drug pricing proposal for the pandemic treaty generates pushback.. statnews.com/pharmalot/2023/… #pharma #pandemic #WHO
European Union drug pricing proposal for the pandemic treaty generates pushback

European Union drug pricing proposal for the pandemic treaty generates pushback

"The European Commission has always been fond of tiered pricing, despite the growing evidence over the last decade and a half that it does not really work," said Ellen ‘t Hoen, a former head of the...

statnews.com
366
Eli Lilly is making some dramatic cuts to list prices of its insulin products.. @matthewherper & I spoke to CEO David Ricks, and also to several experts and a patient advocate who were hopeful but a bit skeptical. statnews.com/pharmalot/2023/… #pharma #diabetes #insulin $LLY $SNY $NVO
Eli Lilly cuts prices for some insulin products, but some are wary

Eli Lilly cuts prices for some insulin products, but some are wary

Eli Lilly, one of the largest makers of insulin, said it would make dramatic cuts to the prices of several of its older insulin products in an effort to lower costs for consumers whose insulin is not...

statnews.com
1
3
1,347
Load more